Commercial Viability of Blue Tea Production in North 24 Parganas District: A Comparative Study with Green Tea
Keywords:
Blue Tea, Sustainable Cost of production , Return on Capital EmployedAbstract
Blue Tea is generally made from Blue Butterfly Pea Flower (scientifically called as ‘CliteriaTernatea. L’ and commonly identified as “Aparajita” or “Neelkanta”) which is a common plant in most of the Southeast Asian countries. The prime objective of the present study is to explore the long-term economic and commercial viability of production of Blue Tea in North 24 Parganas District. Besides, the study comparatively analysed the process, estimated cost and return associated with manufacturing of Blue Tea and Green Tea and highlighted the prospects and challenges associated with Blue Tea as a substitute of Green Tea. Green Tea is chosen for comparison with Blue Tea because flavour of Blue Tea is more or less similar to Green Tea. The study is basically explorative in nature. Most of the data are collected from on-the-spot inspection of manufacturing facility situated in North 24 Parganas district. Various cost and inflation accounting techniques are used to estimate costs and return. The study revealed that in spite of lack of Government support, absence of any kind of research and development, marketing and other promotion related initiatives, Blue Tea production in North 24 Parganas District has shown enormous economic potential.
References
Bewar, D. (2019). Development of mocktail drinks using butterfly pea flower extract. TESDA Women’s Centre.
Chen,H.L., Chen,C.I., Chen,Y.P. & Huang, H.P. (2018). Application of butterfly pea flower extract in mask development. Scientia Pharmaceutica, 86(4), 53.
Gomez, M.S. &Kalamani, A. (2003). Butterfly pea (Clitoriaterna tea): a nutritive multipurpose forage legume for the tropics - an overview. Pakistan Journal of Nutrition, 2 (6), 374-379.
Lakshan, T. A.S., Jayanth, Y.S., Abeysekera, M.K.P.W. &Abeysekera, M.S.K.W.(2019). A commercial potential blue pea (clitoriaternatea l.) flower extract incorporated beverage having functional properties. Hindawi Evidence-Based Complementary and Alternative Medicine, 13.
Madukokila, U.A.A.D., Jemziya, M.B.F., Wijewardhane, R.M.N.A. &Rifath, M.R.A. (2021). Development and Quality Evaluation of Blue Butterfly Pea Flower (Clitoriaternatea L.) Extract Incorporated Jelly. International Conference of Science and Technology (Proceedings of Paper), Faculty of Technology, South Eastern University of Srilanka, 124-129.
Pal, K. (2022, June 29). FelaDeoAparajitaSukiya Neel Chayer Chas. Bartaman, p4.
Sofiah, S., Aswan, A., Yunanto, I., Ramayanti, C., Amelia, P.D.& Utami, A.n. (2021). Making herbal tea from a mixture of butterfly pea flower (ClitoriaTernatea) and ginger powder (Zingiber Officinale) by using drying method according to Indonesian national standards (SNI), Atlantis Highlights in Engineering, 19,107-114.
Suebkhampet, A. & Sotthibandhu, P. (2011). Effect of using aqueous crude extract from butterfly pea flowers (ClitoriaT ernatea L.) as a dye on animal blood smear staining, Suranaree J. Sci. Technol, 19(1), 15-19.
Tiwari, R.K. & Chauhan, S.K. (18 November, 2016). Energy requirement and cost economics in tea cultivation and processing in organic condition, The Sangai Express.
Weerasinghe, T., Peera, D., Silva, N.D., Poogoda, D. & Swarnathilaka, H. (2022). Butterfly pea: an emerging plant with applications in food and medicine, The Pharma Innovation Journal, 11(6), 625-637.
http:// www.okcredit.com
https://www.pubmed.ncbi.nlm.nih.gov.
https://www.ranosys.com/blog/insights/moving-from-b2b-to-d2c-business-model.
https://www.researchandmarkets.com/reports/5233742/butterfly-pea-flowers-market-by-type-whole-dried.
Downloads
Published
Issue
Section
License
The entire contents of the Indian Journal of Accounting are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights.